Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Around 7% of the Indian population suffers from IBS
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
The company plans to add 1700 beds by FY27 through the organic route
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Subscribe To Our Newsletter & Stay Updated